Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Hemoglobin

Retrieve available abstracts of 141 articles:
HTML format

Single Articles

    August 2022
  1. AMARASINGHA AADS, Silva HJRL, Perera PS, Premawardhena AP, et al
    Anemia in Sri Lanka: A Literature Review.
    Hemoglobin. 2022 Aug 24:1-11. doi: 10.1080/03630269.2022.2096460.
    PubMed     Abstract available

    July 2022
  2. BAO XQ, Wang JC, Qin DQ, Yao CZ, et al
    A Novel 5 kb Deletion in the beta-Globin Gene Cluster Identified in a Chinese Patient.
    Hemoglobin. 2022;46:245-248.
    PubMed     Abstract available

  3. WARANG PP, Shinde NS, Umare VD, Deshmukh PV, et al
    Role of Oxidative Stress and the Protective Effect of Fermented Papaya Preparation in Sickle Cell Disease.
    Hemoglobin. 2022;46:260-264.
    PubMed     Abstract available

  4. FARMAKIS D, Angastiniotis M, El Ghoul MM, Cannon L, et al
    Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation.
    Hemoglobin. 2022;46:225-232.
    PubMed     Abstract available

  5. LAM TT, Nguyen DT, Le QT, Nguyen DA, et al
    Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve alpha- and beta-Thalassemia Carrier Screening in Pregnant Women in Vietnam.
    Hemoglobin. 2022;46:233-239.
    PubMed     Abstract available

  6. LOCKE M, Reddy PS, Badawy SM
    Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review.
    Hemoglobin. 2022;46:201-213.
    PubMed     Abstract available

  7. LIN XM, Jiang F, Li J, Li DZ, et al
    Dominantly Inherited beta-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the beta-Globin Gene: Hb Xiangyang (HBB: c.393delT).
    Hemoglobin. 2022;46:253-255.
    PubMed     Abstract available

  8. SEN A, Sen A, Dolai TK
    Diagnostic Dilemma of Hemoglobinopathies Using High Performance Liquid Chromatography Alone: A Case Report from a Resource-Constrained Setting.
    Hemoglobin. 2022;46:256-259.
    PubMed     Abstract available

  9. LIAO J, Li Q, Ling LQ, Liu CN, et al
    A Triple-Heterozygous beta-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel beta(0) Mutation [an IVS-II-654 (C>T) mutation with a Hb Zurich-Langstrasse (HBB: c.151A>T) mutation in cis].
    Hemoglobin. 2022;46:249-252.
    PubMed     Abstract available

  10. ZHANG L, Bao LJ, Hong ZD, Yan MX, et al
    Dysregulated Serum Cytokine Production in Pediatric Patients with beta-Thalassemia Major.
    Hemoglobin. 2022;46:191-196.
    PubMed     Abstract available

    May 2022
  11. MANCO L, Santos R, Rocha C, Relvas L, et al
    Hb F Levels in beta-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the beta-Globin Gene Cluster.
    Hemoglobin. 2022;46:168-175.
    PubMed     Abstract available

  12. REN ZM, Xing ZH, Chen SL, Fu XY, et al
    Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing.
    Hemoglobin. 2022;46:160-163.
    PubMed     Abstract available

  13. KURUCU B, Fettah A, Capkinoglu E, Oner N, et al
    Dynamic Thiol-Disulfide Homeostasis in Children With beta-Thalassemia Trait.
    Hemoglobin. 2022;46:164-167.
    PubMed     Abstract available

  14. KHAMPHIKHAM P, Sakkhachornphop S, Pongsatha S, Pornprasert S, et al
    Strong Positive Dichlorophenolindophenol Precipitation Suggests Hb Dhonburi (or Hb Neapolis) (HBB: c.380T>G) Inheritance in a Couple at Risk for Severe beta-Thalassemia.
    Hemoglobin. 2022;46:184-186.
    PubMed     Abstract available

  15. PARSASEFAT M, Safarpour H, Nomiri S, Miri-Moghaddam E, et al
    Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through CA1 and LIN28B Genes: An In Vitro Study.
    Hemoglobin. 2022;46:153-159.
    PubMed     Abstract available

  16. MORADI K, Aznab M, Azimi A, Biglari M, et al
    alpha-Thalassemia Mutations in Ilam Province, West Iran.
    Hemoglobin. 2022;46:147-152.
    PubMed     Abstract available

    March 2022
  17. VARELAS C, Gavriilaki E, Sakellari I, Klonizakis F, et al
    Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Hemoglobin. 2022;46:143-145.
    PubMed     Abstract available

  18. MANGANAS K, Delicou S, Xydaki A, Koskinas J, et al
    Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Hemoglobin. 2022;46:114-117.
    PubMed     Abstract available

  19. ZARKADA E, Yfanti E, Teli A, Balassopoulou A, et al
    Rare Pathogenic beta(0)-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece.
    Hemoglobin. 2022;46:140-142.
    PubMed     Abstract available

  20. SAHA D, Chowdhury PK, Panja A, Pal D, et al
    Effect of deletions in the alpha-globin gene on the phenotype severity of beta-thalassemia.
    Hemoglobin. 2022;46:118-123.
    PubMed     Abstract available

  21. EFSTATHIOU A, Boutou E, Teli A, Drikos I, et al
    A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.
    Hemoglobin. 2022;46:132-136.
    PubMed     Abstract available

  22. KITTIPOOM T, Tantiworawit A, Punnachet T, Hantrakun N, et al
    The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database.
    Hemoglobin. 2022;46:75-80.
    PubMed     Abstract available

  23. JIANG F, Chen GL, Li J, Tang XW, et al
    beta-Thalassemia Intermedia Caused by the beta-Globin Gene 3' Untranslated Region: Another Case Report.
    Hemoglobin. 2022;46:137-139.
    PubMed     Abstract available

  24. KARAKAYA T, Silan F, Ozdemir O
    A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.
    Hemoglobin. 2022;46:87-90.
    PubMed     Abstract available

  25. ZAMAN BA, Ibrahim SA
    Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in beta-Thalassemia Major Patients.
    Hemoglobin. 2022;46:106-113.
    PubMed     Abstract available

  26. BICILIOGLU Y, Bal A, Demir Yenigurbuz F, Ergonul E, et al
    Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.
    Hemoglobin. 2022;46:95-99.
    PubMed     Abstract available

    Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital.
    Hemoglobin. 2022;46:91-94.
    PubMed     Abstract available

    January 2022
  28. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    PubMed     Abstract available

  29. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    PubMed     Abstract available

  30. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    PubMed     Abstract available

  31. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    PubMed     Abstract available

  32. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    PubMed     Abstract available

  33. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    PubMed     Abstract available

  34. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    PubMed     Abstract available

  35. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.

  36. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    PubMed     Abstract available

  37. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    PubMed     Abstract available

  38. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    PubMed     Abstract available

  39. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    PubMed     Abstract available

  40. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    PubMed     Abstract available

  41. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    PubMed     Abstract available

  42. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    PubMed     Abstract available

  43. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    PubMed     Abstract available

  44. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    PubMed     Abstract available

    November 2021
  45. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    PubMed     Abstract available

  46. DEHURY S, Mohanty PK, Patel S, Meher S, et al
    Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with alpha-Thalassemia and beta-Globin Gene Cluster Haplotypes from Odisha, India.
    Hemoglobin. 2021;45:380-386.
    PubMed     Abstract available

  47. CHAN NCN, Wong THY, Cheng KCK, Chan NPH, et al
    An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong.
    Hemoglobin. 2021;45:387-391.
    PubMed     Abstract available

  48. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Hemoglobin. 2021;45:371-379.
    PubMed     Abstract available

  49. FARRA C, Abdouni L, Souaid M, Awwad J, et al
    The Spectrum of beta-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
    Hemoglobin. 2021;45:365-370.
    PubMed     Abstract available

  50. TSITSIKAS DA, Kamal M, Braimoh A, Benson S, et al
    Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
    Hemoglobin. 2021;45:355-357.
    PubMed     Abstract available

  51. ALIYEVA G, Abdulalimov E, Asadov C, Mammadova T, et al
    First Report of beta-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T) Mutations.
    Hemoglobin. 2021;45:347-348.
    PubMed     Abstract available

    September 2021
  52. HUANG LF, Yu LL, Nikuze L, Singh S, et al
    Spectrum of beta-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0-15 Years.
    Hemoglobin. 2021;45:318-321.
    PubMed     Abstract available

    Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
    Hemoglobin. 2021;45:287-295.
    PubMed     Abstract available

  54. YADAV DD, Jamwal M, Singh N, Sharma R, et al
    Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing.
    Hemoglobin. 2021;45:338-340.
    PubMed     Abstract available

  55. RUENGDIT C, Punyamung M, Khamphikham P, Pongpunyayuen P, et al
    Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia.
    Hemoglobin. 2021;45:309-313.
    PubMed     Abstract available

  56. TRUTTMANN R, Schmidt A, Hartmann B, Rusch S, et al
    Description of Hb Evora (HBA2: c.106T>C) on an Unexpected Allele in a Swiss Family.
    Hemoglobin. 2021;45:314-317.
    PubMed     Abstract available

  57. ZAHRA A, Ragab A, Al-Abboh H, Ismaiel A, et al
    Perforated Duodenal Ulcer Associated with Deferasirox in a Child with beta-Thalassemia Major.
    Hemoglobin. 2021;45:335-337.
    PubMed     Abstract available

  58. CHEN HQ, Wu LS, Jiang F, Li DZ, et al
    Dominant beta-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
    Hemoglobin. 2021;45:329-331.
    PubMed     Abstract available

  59. SEN A, Seenappa V, Chakrabarti P, Dolai TK, et al
    First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the beta-Globin Gene in the Indian Population.
    Hemoglobin. 2021;45:325-328.
    PubMed     Abstract available

  60. DELICOU S, Aggeli K, Magganas K, Patsourakos D, et al
    Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
    Hemoglobin. 2021;45:303-308.
    PubMed     Abstract available

  61. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Hemoglobin. 2021;45:275-286.
    PubMed     Abstract available

  62. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable alpha Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.
    Hemoglobin. 2021;45:322-324.
    PubMed     Abstract available

  63. TRIPATHY I, Panja A, Dolai TK, Mallick AK, et al
    Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali beta-Thalassemia Major Children.
    Hemoglobin. 2021;45:296-302.
    PubMed     Abstract available

    July 2021
  64. ATROSHI SD, Al-Allawi NAS, Eissa AA
    Updated Molecular Spectrum of beta-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Hemoglobin. 2021;45:239-244.
    PubMed     Abstract available

  65. PERERA S, Allen A, Rees DC, Premawardhena A, et al
    Pitfalls in the Diagnosis of beta-Thalassemia Intermedia.
    Hemoglobin. 2021;45:265-268.
    PubMed     Abstract available

  66. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.
    Hemoglobin. 2021;45:256-258.
    PubMed     Abstract available

  67. ETEMAD K, Mohseni P, Aghighi M, Bahadorimonfared A, et al
    Quality of Life and Related Factors in beta-Thalassemia Patients.
    Hemoglobin. 2021;45:245-249.
    PubMed     Abstract available

  68. UCUCU S, Karabiyik T, Azik FM
    IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/beta(+)-Thalassemia Phenotype in an Hb S Trait Patient.
    Hemoglobin. 2021;45:225-227.
    PubMed     Abstract available

  69. IDRIS IM, Yusuf AA, Gwarzo DH, Kurawa MS, et al
    High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
    Hemoglobin. 2021;45:228-233.
    PubMed     Abstract available

  70. MARTIN G, Grimholt RM, Le D, Bechensteen AG, et al
    Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a beta-Thalassemia Major Phenotype.
    Hemoglobin. 2021;45:215-219.
    PubMed     Abstract available

  71. RAFAT M, Allamehzadeh Z, Shekari M, Afsa M, et al
    The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the beta-Globin Promoter: Case Series Study.
    Hemoglobin. 2021;45:234-238.
    PubMed     Abstract available

  72. JIANG F, Tang XW, Li J, Zhou JY, et al
    Hb Lepore-Hong Kong: First Report of a Novel delta/beta-Globin Gene Fusion in a Chinese Family.
    Hemoglobin. 2021;45:220-224.
    PubMed     Abstract available

    June 2021
  73. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    PubMed     Abstract available

    May 2021
  74. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    PubMed     Abstract available

  75. BROWN BJ, Madu A, Sangeda RZ, Nkya S, et al
    Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Hemoglobin. 2021;45:163-170.
    PubMed     Abstract available

  76. TSOLAKIDIS V, Vlachaki E, Papaioannou M, Pantelidou D, et al
    Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece.
    Hemoglobin. 2021;45:143-149.
    PubMed     Abstract available

  77. MOORE JA, Pullon BM, Wang D, Brennan SO, et al
    Hb Tacoma: G>T or G>C, and Does It Matter?
    Hemoglobin. 2021;45:203-206.
    PubMed     Abstract available

  78. SOOD R, Rastogi P, Bansal D, Das R, et al
    An Autopsy Case of beta-Thalassemia Major Illuminating the Pathological Spectrum of the Disease.
    Hemoglobin. 2021;45:180-185.
    PubMed     Abstract available

  79. ATROSHI SD, Al-Allawi N, Chui DHK, Najmabadi H, et al
    A Novel beta(0)-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd.
    Hemoglobin. 2021;45:212-214.
    PubMed     Abstract available

  80. SAENSUWANNA A, Penglong T, Srinoun K
    Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF4.
    Hemoglobin. 2021;45:197-202.
    PubMed     Abstract available

  81. RUJEERAPAIBOON N, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
    Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients.
    Hemoglobin. 2021;45:175-179.
    PubMed     Abstract available

  82. THEPPORNPITAK K, Trakarnsanga B, Lauhasurayotin S, Poparn H, et al
    A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2021;45:171-174.
    PubMed     Abstract available

  83. LUO LP, Ma L, Lin SB, Huang JG, et al
    Elevated Hb A2 is Not Always Indicative of beta-Thalassemia.
    Hemoglobin. 2021;45:186-190.
    PubMed     Abstract available

  84. SAHA J, Panja A, Nayek K
    The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/beta-Thalassemia Children in a Tertiary Center of West Bengal, India.
    Hemoglobin. 2021;45:157-162.
    PubMed     Abstract available

  85. TIAN Q, Lei YL, Xu LL, Li DZ, et al
    First Report of Nondeletional Hb H Disease Caused by an alpha2-Globin Gene Mutation: HBA2: c.184A>T.
    Hemoglobin. 2021;45:210-211.
    PubMed     Abstract available

    March 2021
  86. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    PubMed     Abstract available

  87. OGU UO, Reyes Gil M, Tolu SS, Acharya SA, et al
    First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G).
    Hemoglobin. 2021;45:136-139.
    PubMed     Abstract available

  88. YIN Z, Hao Y, Huang X, Chen X, et al
    A Novel Mutation at HBA1: c.349G>T Causing alpha-Thalassemia in a Chinese Family.
    Hemoglobin. 2021;45:94-96.
    PubMed     Abstract available

  89. MARTINEZ VILLEGAS O, Mendoza-Melendez D, Trueba-Gomez R, Rosenfeld-Mann F, et al
    Analysis of a Novel Mexican Variant of the HBB Gene Associated with beta-Thalassemia Using Bioinformatic Tools.
    Hemoglobin. 2021;45:87-93.
    PubMed     Abstract available

  90. INATI A, Al Alam C, El Ojaimi C, Hamad T, et al
    Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
    Hemoglobin. 2021;45:80-86.
    PubMed     Abstract available

  91. PANICHCHOB P, Iamdeelert P, Wongsariya P, Wongsariya P, et al
    Molecular Spectrum of beta-Thalassemia Mutations in Central to Eastern Thailand.
    Hemoglobin. 2021;45:97-102.
    PubMed     Abstract available

  92. SHARIFI F, Safizadeh H, Bahrampour A
    Development of the Quality of Life Questionnaire (SF-36) for Patients with beta-Thalassemia Major and beta-Thalassemia Intermedia Based on Extended Rasch Analysis.
    Hemoglobin. 2021;45:119-123.
    PubMed     Abstract available

  93. ZARDKHONI SZ, Moghaddam AG, Rad F, Ghatee MA, et al
    Serum Zinc Level in beta-Thalassemia Major: A Retrospective Study in Southwest Iran.
    Hemoglobin. 2021;45:103-106.
    PubMed     Abstract available

  94. ZHAO YL, Lin QF, He XW, Li YQ, et al
    Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.
    Hemoglobin. 2021;45:133-135.
    PubMed     Abstract available

  95. SOLTANI D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, et al
    Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with beta-Thalassemia Major.
    Hemoglobin. 2021;45:107-111.
    PubMed     Abstract available

  96. COLAH RB, Nadkarni AH, Gorakshakar AC, Sawant PM, et al
    The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades.
    Hemoglobin. 2021;45:112-118.
    PubMed     Abstract available

  97. RUENGDIT C, Khamphikham P, Jinorose N, Pornprasert S, et al
    Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -(CR)) alpha(0)-Thalassemia in Two Unrelated Thai Families.
    Hemoglobin. 2021;45:75-79.
    PubMed     Abstract available

  98. WANG RY, Jiang F, Xu LL, Li DZ, et al
    Mild alpha-Thalassemia Caused by a Mosaic alpha-Globin Gene Mutation.
    Hemoglobin. 2021;45:140-141.
    PubMed     Abstract available

    January 2021
  99. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    PubMed     Abstract available

  100. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    PubMed     Abstract available

  101. CHEN X, Lin Z, Hu J, Chen S, et al
    Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.
    Hemoglobin. 2021;45:52-55.
    PubMed     Abstract available

  102. LIU L, Sun Y, Chen S, Yu C, et al
    Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.
    Hemoglobin. 2021;45:49-51.
    PubMed     Abstract available

  103. AL-ZUHAIRY SH, Darweesh MA, Othman MA
    Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with beta-Thalassemia Major.
    Hemoglobin. 2021;45:69-73.
    PubMed     Abstract available

  104. BALLAS SK, Riddick-Burden G, Congdon-Martin E
    Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs.
    Hemoglobin. 2021;45:62-65.
    PubMed     Abstract available

  105. TARIQ A, Khurshid S, Sajjad M
    Evaluation of the High Resolution Melting Approach for Detection of beta-Thalassemia Gene Mutations.
    Hemoglobin. 2021;45:20-24.
    PubMed     Abstract available

  106. LIN QY, Chen DY, Kong S, Liu WQ, et al
    A Rare Case of Hb H Disease and Systemic Lupus Erythematosus.
    Hemoglobin. 2021;45:66-68.
    PubMed     Abstract available

  107. WANG WJ, Ding ZX, Zhang HM, Tao TT, et al
    Identification of a Novel beta-Thalassemia Mutation at Codon 130 (+T) (HBB: c.391insT) in Han Chinese.
    Hemoglobin. 2021;45:46-48.
    PubMed     Abstract available

  108. GOLLAMUDI J, Sarvepalli S, Vadaparti Binf A, Alin T, et al
    Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.
    Hemoglobin. 2021;45:56-59.
    PubMed     Abstract available

  109. SIGAL IR, Ciunci CA
    Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
    Hemoglobin. 2021;45:60-61.
    PubMed     Abstract available

  110. DOULGERAKI A, Fragodimitri C, Athanasopoulou H, Drakaki K, et al
    Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
    Hemoglobin. 2021;45:30-36.
    PubMed     Abstract available

  111. AYDOGDU S, Toret E, Aksoy BA, Aydin MF, et al
    Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types.
    Hemoglobin. 2021;45:25-29.
    PubMed     Abstract available

  112. ANGASTINIOTIS M, Petrou M, Loukopoulos D, Modell B, et al
    The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.
    Hemoglobin. 2021;45:5-12.
    PubMed     Abstract available

  113. LIEDERMAN Z, Quartey NK, Ward R, Papadakos J, et al
    Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care.
    Hemoglobin. 2021;45:13-19.
    PubMed     Abstract available

    November 2020
  114. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    PubMed     Abstract available

    July 2020
  115. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    PubMed     Abstract available

    March 2020
  116. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    PubMed     Abstract available

  117. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    PubMed     Abstract available

  118. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    PubMed     Abstract available

  119. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    PubMed     Abstract available

  120. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    PubMed     Abstract available

  121. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    PubMed     Abstract available

  122. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    PubMed     Abstract available

  123. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    PubMed     Abstract available

  124. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    PubMed     Abstract available

  125. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    PubMed     Abstract available

  126. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    PubMed     Abstract available

  127. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    PubMed     Abstract available

  128. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    PubMed     Abstract available

    January 2020
  129. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    PubMed     Abstract available

  130. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    PubMed     Abstract available

  131. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    PubMed     Abstract available

  132. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    PubMed     Abstract available

  133. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    PubMed     Abstract available

  134. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    PubMed     Abstract available

  135. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    PubMed     Abstract available

  136. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    PubMed     Abstract available

  137. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    PubMed     Abstract available

  138. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    PubMed     Abstract available

  139. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    PubMed     Abstract available

  140. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    PubMed     Abstract available

  141. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.